High‐Performance Liquid Chromatography–Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl‐Biphenyl‐Tetrazole Impurities in Losartan
Journal of Separation Science · 2024-10 · 47 (19)
DOI: 10.1002/jssc.202400277 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Separation Science, online erschienen am 09.10.2024. Verfasst von Nguyen Minh Luan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry and Drug Quality Control, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. Hauptthemen laut MEDLINE: Nitrosamines, Tandem Mass Spectrometry, Drug Contamination, Losartan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Nitrosamine‐related impurities ( N ‐nitrosomethylamino butyric acid [NMBA], N ‐nitrosodiethylamine [NDEA], N ‐nitrosodiisopropylamine [NDIPA], N ‐nitrosomethylphenylamine [NMPA], N ‐nitrosodibutylamine [NDBA], N ‐nitrosodimethylamine [NDMA], and N ‐nitrosoethylisopropylamine [NEIPA]) and 5‐[4'‐(azidomethyl)‐[1,1'‐biphenyl]‐2‐yl]‐2H‐tetrazole (AZBT) formed during the manufacture of sartan medicines have been classified into human mutagens and carcinogens after long‐term treatment. The study developed a simple, economical but highly sensitive procedure for the simultaneous quantification of seven nitrosamines and AZBT impurities in sartan pharmaceuticals. After extraction with methanol (MeOH) 50%, the compounds were analyzed with a reversed‐phase liquid chromatography–tandem mass spectroscopy with atmospheric‐pressure chemical ionization (APCI) mode (APCI[+] for nitrosamines and APCI[−] for AZBT), selected reaction monitoring, C18 column, gradient elution with 0.1% formic acid in water and in MeOH, respectively. The validated procedure obtained high extraction efficiency (>90%), wide linear range (0.2–50.0 ng/mL NMBA, NDEA, NDIPA, NMPA, and NDBA; 0.5–50.0 ng/mL NDMA and NEIPA; 2.0–100 ng/mL AZBT), limit of quantification < 10% of the acceptance level, recovery range of 85%–115% with relative standard deviation < 15% and minimum matrix effects for all impurities. The procedure was applied to test 16 commercial losartan samples. As a result, eight samples contained AZBT within the current regulatory limits, but no nitrosamine impurities were detected in all samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Analytical Chemistry and Drug Quality Control, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam.
ORCID-Profile: Vo Thi Kim Khuyen
Zitieren
APA
Luan, N. M., Khuyen, V. T. K., & Tuan, N. D. (2024). High‐Performance Liquid Chromatography–Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl‐Biphenyl‐Tetrazole Impurities in Losartan. Journal of Separation Science, 47(19). https://doi.org/10.1002/jssc.202400277
Vancouver
Luan NM, Khuyen VTK, Tuan ND. High‐Performance Liquid Chromatography–Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl‐Biphenyl‐Tetrazole Impurities in Losartan. Journal of Separation Science. 2024;47(19). doi:10.1002/jssc.202400277
BibTeX
@article{Luan2024,
author = {Luan, Nguyen Minh and Khuyen, Vo Thi Kim and Tuan, Nguyen Duc},
title = {High‐Performance Liquid Chromatography–Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl‐Biphenyl‐Tetrazole Impurities in Losartan},
journal = {Journal of Separation Science},
year = {2024},
volume = {47},
number = {19},
doi = {10.1002/jssc.202400277}
}
EUVIMED